CAS: 1258595-14-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LHC-165 REF: 3D-IAC59514CAS: 1258595-14-0 | Min. 95% | To inquire | Tue 18 Feb 25 |
 | LHC-165 REF: TM-T15751CAS: 1258595-14-0 | 98% | 614.00 €~3,636.00 € | Tue 08 Apr 25 |
LHC-165
CAS:1258595-14-0
LHC-165 is a biodegradable polymer drug that targets the tumor microenvironment. LHC-165 has been shown …
Formula:
C29H32F2N3O7P
Purity:
Min. 95%
Molecular weight:
603.55 g/mol
Ref: 3D-IAC59514
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
LHC-165
CAS:1258595-14-0
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
Formula:
C29H32F2N3O7P
Purity:
98%
Color and Shape:
Solid
Molecular weight:
603.55
Ref: TM-T15751
| 25mg | 1,827.00 € | ||
| 50mg | 2,402.00 € | ||
| 100mg | 3,636.00 € |
Estimated delivery in United States, on Tuesday 8 Apr 2025
